Yes safety is the least of our issues and many company updates have validated this (when additional patients enrolled into higher dose group for instance)
As everyone has discussed it's not going to be a matter of if we fail , it's how good the positive results are and how the market processes that
Regardless I am dumbfounded that we still sit at 7c as any sort of positive will warrant a much higher share price . The positive language today does make me more excited to unveil p2b results
Even if results are slightly beneficial - it's still much better then the current treatment for retts ie nothing ! This along with the safety profile will receive a green stamp from the FDA at some point . Any result better then just ok is a bonus for everyone .
For the record I think the 200mg/kg dose will produce some very strong benefits in particular to anxiety and improved alertness.
NEU Price at posting:
6.9¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)